PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.46%
Revenue growth of 30.46% while ACB.TO is flat. Bruce Berkowitz would check if a small edge can widen further.
41.93%
Gross profit growth of 41.93% while ACB.TO is zero. Bruce Berkowitz would see if minimal improvements could expand further.
82.60%
EBIT growth 50-75% of ACB.TO's 160.42%. Martin Whitman would suspect suboptimal resource allocation.
82.60%
Operating income growth at 50-75% of ACB.TO's 156.97%. Martin Whitman would doubt the firm’s ability to compete efficiently.
100.85%
Net income growth at 50-75% of ACB.TO's 143.31%. Martin Whitman would question fundamental disadvantages in expenses or demand.
101.37%
EPS growth at 50-75% of ACB.TO's 142.22%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
100.00%
Diluted EPS growth at 50-75% of ACB.TO's 138.52%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
20.86%
Share count expansion well above ACB.TO's 12.62%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
61.58%
Diluted share count expanding well above ACB.TO's 12.62%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-1.79%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
16.41%
Positive FCF growth while ACB.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
81.23%
Positive long-term OCF/share growth while ACB.TO is negative. John Neff would see a structural advantage in sustained cash generation.
81.23%
Positive OCF/share growth while ACB.TO is negative. John Neff might see a comparative advantage in operational cash viability.
35.95%
Positive 3Y OCF/share CAGR while ACB.TO is negative. John Neff might see a big short-term edge in operational efficiency.
100.20%
Net income/share CAGR at 75-90% of ACB.TO's 132.77%. Bill Ackman would press for strategic moves to boost long-term earnings.
100.20%
Below 50% of ACB.TO's 257.09%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
101.39%
3Y net income/share CAGR 50-75% of ACB.TO's 202.20%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
172.44%
Positive growth while ACB.TO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
172.44%
Positive 5Y equity/share CAGR while ACB.TO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
350.35%
Positive short-term equity growth while ACB.TO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.68%
AR growth well above ACB.TO's 16.23%. Michael Burry fears inflated revenue or higher default risk in the near future.
-10.75%
Inventory is declining while ACB.TO stands at 923.82%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
100.93%
Asset growth above 1.5x ACB.TO's 20.61%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
76.87%
1.25-1.5x ACB.TO's 67.19%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
42.65%
R&D growth drastically higher vs. ACB.TO's 12.95%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.32%
SG&A declining or stable vs. ACB.TO's 41.72%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.